Ms. Melissa Ann Cole, ED.S, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 801 Northbrook Pl, Monroeville, NJ 08343 Phone: 856-405-1707 |
Michael Kuzma, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1031 Elk Rd, Monroeville, NJ 08343 Phone: 609-233-8286 |
News Archive
In the BMJ Groups blog, Amanda Glassman, director of the global health policy program at the Center for Global Development (CGD), and her colleagues at CGD examine "whether universal health coverage (UHC) as a post-2015 development goal is a good idea."
Using evidence found in baby teeth, researchers from The Senator Frank R. Lautenberg Environmental Health Sciences Laboratory and The Seaver Autism Center for Research and Treatment at Mount Sinai found that differences in the uptake of multiple toxic and essential elements over the second and third trimesters and early postnatal periods are associated with the risk of developing autism spectrum disorders (ASD), according to a study published June 1 in the journal Nature Communications.
Almost half of all U.S. adults who experienced physical or psychological problems in the months following the 9/11 terrorist attacks still struggle with feelings of fear and anxiety 10 years later, today's Harris Interactive/HealthDay poll found.
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
› Verified 4 days ago